Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A3573 LY2801653Target: METSummary: MET inhibitor
-
A3624 MK-8033Summary: C-MET inhibitor
-
A3712 PF-04217903 methanesulfonateTarget: c-METSummary: C-Met inhibitor,selective and ATP-competitive
-
A3847 SU5416Target: VEGFRSummary: VEGF receptor inhibitor and AHR agonist
-
B2302 ZM 323881 HClSummary: selective VEGFR2 inhibitor
-
B1438 BMS-794833Target: MET|Flk-1Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive
-
A8361 AMG-458Summary: Potent c-Met inhibitor
-
A8448 INCB28060Target: c-METSummary: C-Met inhibitor,ATP-competitive and novel
-
A8489 NVP-BVU972Summary: C-Met inhibitor,potent and selective
-
A3020 (R)-Crizotinib2 CitationTarget: c-METSummary: C-MET/ALK inhibitor,potent and ATP-competitve